Publications
5808 Results
- Journal / Conference
- Journal of Clinical Oncology 29(33):4348-4350
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Gastric Cancer: Nagoya is not New York [PMID22010021]
- Journal / Conference
- Clinical Trials 8(5):591-600
- Year
- 2011
- Research Committee(s)
- Multiple sites
Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials [PMID20595245; PMC3474201]
- Journal / Conference
- Journal of Clinical Oncology 29:2011 (suppl 7; abstr 3); ASCO GU symposium (poster presentation)
- Year
- 2011
- Research Committee(s)
- Genitourinary
A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK intercontinental trial CRUKE/01/013
- Journal / Conference
- Lancet 378(9809):2104-2111
- Year
- 2011
- Research Committee(s)
- Genitourinary
- PMID
- PMID22056152
- PMC
- PMC3243932
- Study Number(s)
- JPR3
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
- Journal / Conference
- Blood 118:abstract 661 (oral presentation)
- Year
- 2011
- Research Committee(s)
- Lymphoma
Randomized phase III trial of 131 iodine-tositumomab (Bexxar)/carmustine, etoposide, cytarabine, melphalan (BEAM) vs. rituximab/BEAM and autologous stem cell transplantation for relapsed diffuse large B-cell lymphoma (DLBCL): no difference in progression-free (PFS) or overall survival (OS)
- Journal / Conference
- Haematologica 96(s1):S78, poster #167 (International Myeloma Workshop)
- Year
- 2011
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0232
Extended results of Southwest Oncology Group protocol S0232: durable responses achieved with lenalidomide (L) plus high-dose dexamethason (D) as first-line therapy for multiple myeloma
- Journal / Conference
- Health Affairs 30(12):2259-2268
- Year
- 2011
- Research Committee(s)
- Breast
- PMID
- PMID22147853
- PMC
- PMC3477796
- Study Number(s)
- S1007
How comparativeness effectiveness research can help advance "personalized medicine" in cancer treatment
- Journal / Conference
- Breast Cancer Research and Treatment 126(1):215-220
- Year
- 2011
- Research Committee(s)
- Breast
- PMID
- PMID20976543
- PMC
- pending
Evaluation of metformin in early breast cancer: a modification of the traditional pardigm for clinical testing of anti-cancer agents
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl; abstr TPS103), ASCO annual meeting, Trials in Progress, poster presentation;
- Year
- 2011
- Research Committee(s)
- Breast
A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32)
- Journal / Conference
- Journal of Clinical Oncology 29(25):3366-3373
- Year
- 2011
- Research Committee(s)
- Breast
- PMID
- PMID21768458
- PMC
- PMC3164242
- Study Number(s)
- N9831